1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pancreatic cancer prognosis is predicted by chromatin accessibility microarray
    Meeting Abstract

    Dhara, S.; Chhangawala, S.; Chintalapudi, H.; Massa, A. L.; Aveson, V.; Askan, G.; Zhang, L.; Nicolle, R.; Makohon-Moore, A. P.; Sinha, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A nuclear cAMP microdomain suppresses tumor growth by Hippo Pathway inactivation
    Meeting Abstract

    Drozdz, M. M.; Doane, A.; Desman, G.; Wang, J.; Reilly, M.; Aguirre, K.; Kane, E.; Wolchok, J.; Merghoub, T.; Elemento, O.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Pulsatile MEK inhibition improves anti-tumor immunity and T cell function in Kras mutant lung cancer
    Meeting Abstract

    Choi, H.; Deng, J.; Li, S.; Silk, T.; Dong, L.; Brea, E. J.; Houghton, S.; Redmond, D.; Zhong, H.; Boiarsky, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Combined inhibition of androgen signaling and apoptosis pathways in hormone sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Jehane, L. E.; Mazzu, Y. Z.; Yoshikawa, Y.; Rajanala, S. H.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma
    Meeting Abstract

    Campbell, N. R.; Zhang, M.; Baron, M.; Heilmann, S.; Deforet, M.; Ferretti, L.; Huang, T. H.; Levesque, M. P.; Yanai, I.; Xavier, J. B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Impact of the EML4-ALK fusion variant on the efficacy of lorlatinib in patients (pts) with ALK-positive advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Bauer, T. M.; Martini, J. F.; Besse, B.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Toffalorio, F.; Abbattista, A.; Thurm, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors
    Meeting Abstract

    Bendell, J. C.; Bedard, P.; Bang, Y. J.; LoRusso, P.; Hodi, S.; Gordon, M.; D'Angelo, S.; Desai, J.; Garralda, E.; Italiano, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save